Clinical trials at Melanoma Institute Australia

Clinical trials have always been a very important part of the our research activities, such that the Institute is recognised as one of the most active surgical research centres of any type in Australasia, if not the world. Participation in melanoma clinical trials is well above the NSW Health benchmark of 10% with the Institute attracting sponsors and collaborative investigator groups from all over the world.

Clinical research started at the Melanoma Institute Australia in the late 1960s, then known as the Sydney Melanoma Unit. Since then, the large number of patients willing to participate in clinical trials has enabled the Institute to make major contributions to many critically important clinical research activities, several of which have resulted in changes to the day-to-day management of melanoma patients in Australia and overseas. Current trials are assessing the value of surgery, radiotherapy, chemotherapy and immunotherapy treatments.

Clinical trials facilitated by the Institute are typically multi-site and require teams of doctors, nurses, scientists, research assistants, data managers, pharmacists, and other health professionals. Trials are strictly regulated and are overseen by Ethics Committees comprising of representatives from both the research and general community.